132 related articles for article (PubMed ID: 24693450)
1. Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy.
Suwijn SR; Berendse HW; Verschuur CV; de Bie RM; Booij J
ISRN Neurol; 2014; 2014():345132. PubMed ID: 24693450
[TBL] [Abstract][Full Text] [Related]
2. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Extrastriatal
Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
[No Abstract] [Full Text] [Related]
4. SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias.
Suwijn SR; Berendse HW; Verschuur CV; Winogrodzka A; de Bie RM; Booij J
EJNMMI Res; 2013 Jun; 3(1):44. PubMed ID: 23738774
[TBL] [Abstract][Full Text] [Related]
5. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
6. Topography of Dopamine Transporter Availability in the Cerebellar Variant of Multiple System Atrophy.
Nocker M; Seppi K; Boesch S; Donnemiller E; Virgolini I; Wenning GK; Poewe W; Scherfler C
Mov Disord Clin Pract; 2017; 4(3):389-396. PubMed ID: 30363469
[TBL] [Abstract][Full Text] [Related]
7. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
[TBL] [Abstract][Full Text] [Related]
8. [123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients.
Haapaniemi TH; Ahonen A; Torniainen P; Sotaniemi KA; Myllylä VV
Mov Disord; 2001 Jan; 16(1):124-30. PubMed ID: 11215571
[TBL] [Abstract][Full Text] [Related]
9. Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]β-CIT SPECT.
Nocker M; Seppi K; Donnemiller E; Virgolini I; Wenning GK; Poewe W; Scherfler C
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1012-20. PubMed ID: 22460689
[TBL] [Abstract][Full Text] [Related]
10. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
Strecker K; Wegner F; Hesse S; Becker GA; Patt M; Meyer PM; Lobsien D; Schwarz J; Sabri O
J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
[TBL] [Abstract][Full Text] [Related]
11. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
Varrone A; Marek KL; Jennings D; Innis RB; Seibyl JP
Mov Disord; 2001 Nov; 16(6):1023-32. PubMed ID: 11748733
[TBL] [Abstract][Full Text] [Related]
12. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
[TBL] [Abstract][Full Text] [Related]
13. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
[TBL] [Abstract][Full Text] [Related]
16. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.
Kaasinen V; Kankare T; Joutsa J; Vahlberg T
J Nucl Med; 2019 Dec; 60(12):1757-1763. PubMed ID: 30979821
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-TRODAT-1 imaging of multiple system atrophy.
Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
[TBL] [Abstract][Full Text] [Related]
19. Midbrain serotonin transporters in de novo and L-DOPA-treated patients with early Parkinson's disease--a [123 I]-ADAM SPECT study.
Beucke JC; Plotkin M; Winter C; Endrass T; Amthauer H; Juckel G; Kupsch A
Eur J Neurol; 2011 May; 18(5):750-5. PubMed ID: 21143705
[TBL] [Abstract][Full Text] [Related]
20. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.
Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O
Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
